Eurazeo (RF) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Nov, 2026Executive summary
9M AUM rose 8% YoY to €40.4bn, including third-party AUM growth of 13% to €31.5bn; total asset-management fees increased 8% to €338m.
Fundraising reached €2.8bn; 31 new institutional LPs joined, and LPs outside France accounted for over 75% of institutional flows.
Strategic priorities include scaling asset management, accelerating the asset-light transition, realizing portfolio investments and returning capital to shareholders.
Financial highlights
9M management fees rose 6% to €322m; third-party fees increased 14% to €247m, including private markets fees up 18%, while balance-sheet fees fell 13% to €75m.
Total asset-management fees grew 8% to €338m; performance fees were €16m, up 58%, including third-party performance fees of €10m, up 24%.
Realizations totaled €2.3bn, up 34% from €1.7bn; deployments were €3.5bn, down 8% YoY.
Third-party fundraising was €2.8bn versus €3.2bn in 9M 2025.
Outlook and guidance
FY 2026 fundraising is expected to exceed €4.5bn.
2026 balance-sheet realizations are expected to reach ~15% of prior-year-end NAV; 13% was completed or announced through 9M.
Aroma-Zone is expected to close in Q4 2026, subject to customary regulatory approvals; acquisition financing is secured.
Share buybacks are expected to continue in 2027, bringing cumulative buybacks to ~25% over the full program.
€8bn of total commitments are available for deployment, including €1.8bn from the balance sheet.
Latest events from Eurazeo
- AUM up 9% to €40bn, EBITDA up 20%, net income near break-even, €1.3bn returned to shareholders.RF
Q2 2026 - Strong fundraising, AUM growth, and asset rotation boosted financial position and returns.RF
Q1 2026 - All 28 AGM resolutions passed amid strong growth, higher dividend, and governance improvements.RF
AGM 2026 - €3.2bn raised, AUM up 5%, and strong exits drive 2.1x returns and higher shareholder payouts.RF
Q3 2025 - Fundraising surged 76% and realizations tripled, driving robust growth and portfolio performance.RF
Q3 2024 - Fundraising up 63% to €2.1bn, AUM and FRE grew, and shareholder returns increased.RF
Q2 2024 - All 22 resolutions passed as strong fundraising, a 10% dividend hike, and strategic progress were reported.RF
AGM 2025 - Q1 2025 fundraising quadrupled, AUM and shareholder returns rose, and portfolio growth was strong.RF
Q1 2025 - Record fundraising and exits drive growth, despite fair value losses; shareholder returns boosted.RF
Q4 2024